| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/15/2004 | WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 04/15/2004 | WO2004030674A1 Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist |
| 04/15/2004 | WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2003103567A3 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040073045 Pyrrolidine derivative and process for producing the same |
| 04/15/2004 | US20040073042 Control agents for living-type free radical polymerization and methods of polymerizing |
| 04/15/2004 | US20040072907 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 04/15/2004 | US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 04/15/2004 | US20040072895 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline forms |
| 04/15/2004 | US20040072893 Antilipemic agents; anticholesterol agents |
| 04/15/2004 | US20040072892 Dipeptidyl aminopeptidase inhibitors; kidney and liver disorders; autoimmune diseases; antiarthritic agents; psoriasis; anticancer agents |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 04/15/2004 | CA2500754A1 Novel nitrosation polymer in organic synthesis |
| 04/15/2004 | CA2500672A1 Piperazine and piperidine derivatives for treatment of neurological diseases |
| 04/14/2004 | EP1408031A1 Pyrolidine derivatives useful in treatment of hepatitis C virus infection |
| 04/14/2004 | EP1408030A1 Novel aliphatic compound, method of synthesis, and method of utilization |
| 04/14/2004 | EP1406893A1 Pyrrolidine bicyclic compounds |
| 04/14/2004 | EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406860A1 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives |
| 04/14/2004 | EP1406859A1 Substituted 4-aminocyclohexanol derivatives |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1406493A1 Administration of agents via the pept-2 transporter |
| 04/14/2004 | EP1375479A9 Pyrrolidine derivative and process for producing the same |
| 04/14/2004 | EP1375465A9 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 04/14/2004 | CN1489587A Proces for synthesis of 5-(4-fluorophenyl)-1-[2R, 4R]-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxypic acid phenylamide |
| 04/14/2004 | CN1489573A Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
| 04/14/2004 | CN1489463A Novel crystal forms of atorvastatin hemi-calcium and process for their preparation as well as novel process for preparing other forms |
| 04/14/2004 | CN1489458A Inhibitors against the production and releaseof inflammator cytokines |
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/13/2004 | US6720335 Sulfonamide inhibitors of aspartyl protease |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6719520 For inhibition of glycogen synthase kinase-3 (gsk-3); treatment and prophylaxis for diabetes, chronic neurodegenerative conditions, mood disorders such as schizophrenia and manic depression and hair loss and cancer |
| 04/08/2004 | WO2004029018A1 Glycerol derivative |
| 04/08/2004 | WO2003051276B1 Therapeutic heterocycles |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2003018553A8 Oral antidiabetic agents |
| 04/08/2004 | US20040068122 Delta1-pyrrolines used as pesticides |
| 04/08/2004 | US20040068121 A key intermediate in the synthesis of atorvastatin calcium |
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/08/2004 | US20040067971 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/08/2004 | US20040067229 Azobenzene derivatives as labeling agents and intermediates thereof |
| 04/07/2004 | EP1405849A1 Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom |
| 04/07/2004 | EP1405636A1 Function regulator for retinoid relative receptor |
| 04/07/2004 | EP1404687A2 Fluorous triphase and other multiphase systems |
| 04/07/2004 | EP1404648A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action |
| 04/07/2004 | EP1404644A2 Novel hydrazones |
| 04/07/2004 | EP1404642A2 Synthesis and intermediates |
| 04/07/2004 | EP1404639A1 Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof |
| 04/07/2004 | EP1404325A2 Method for treating nerve injury caused by surgery |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0910370B1 Compositions comprising a nitrone compound for use in treating uveitis |
| 04/07/2004 | CN1487921A Preparation of non-crystalline at orvastatin calcium |
| 04/07/2004 | CN1487920A Deltal-pyrrolines used as pesticides |
| 04/07/2004 | CN1487919A New mandelic acid derivatives and their use as throbin inhibitors |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144789C Pyrrolidine and piperidine derivatives, producing process and application thereof |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716872 Using the compounds for treating pain, anxiety and various other diseases or conditions. |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716866 Aryl-benzimidazole compounds having antiinfective activity |
| 04/06/2004 | US6716844 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 04/06/2004 | US6716843 Inhibitor of dipeptidyl-peptidase iv |
| 04/06/2004 | US6716832 Arylphenyl-substituted cyclic ketoenols |
| 04/06/2004 | CA2075926C Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them |
| 04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
| 04/01/2004 | WO2004027388A2 Novel green and orange fluorescent labels and their uses |
| 04/01/2004 | WO2004026828A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | WO2004026827A1 Pyrrolidone derivatives as maob inhibitors |
| 04/01/2004 | WO2004026826A1 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 04/01/2004 | WO2004026825A1 Pyrrolidone derivatives as maob inhibitors |
| 04/01/2004 | WO2004026824A1 Process for preparing intermediates |
| 04/01/2004 | WO2004026823A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | WO2004026822A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | WO2004026264A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 04/01/2004 | WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 04/01/2004 | US20040063971 Reacting a pyrrolidin-2,5-dione compound with acetylene compound; anticancer agent |
| 04/01/2004 | US20040063970 Production of N-vinyl pyrrolidone |
| 04/01/2004 | US20040063969 Process for the preparation of amorphous atorvastatin calcium |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063777 Reacting a maleimide compound with an alkyne derivative containing a leaving group, in presence of a base to form end product useful for treating ras-associated diseases in a mammal |
| 04/01/2004 | US20040063776 2-oxo-1-pyrrolidineacetamide derivatives are useful for treating cancer pain and other neuropathic pain |
| 04/01/2004 | US20040063773 Adminstering a pyrrole substituted 2-indolinone compound to a human for the treatment of protein kinase related cellular disorders such as cancer, autoimmune disorders, diabetes, rheumatoid arthritis, angiogenesis and osteoarthritis |
| 04/01/2004 | US20040063760 Sodium channel modulatiors |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 04/01/2004 | US20040063645 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide) |